Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2964 |  DMAC DiaMedica Therapeutics Inc. - Common Stock | 8.01 USD | +0.25% | -5.65% | +21.92% | +14.92% | 431.94 M USD | ||
| 2978 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 9.15 USD | -2.24% | -5.67% | -32.17% | -51.84% | 424.36 M USD | ||
| 2991 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 5.16 USD | +2.99% | 0.00% | -1.15% | +60.75% | 413.86 M USD | ||
| 2998 |  YDES YD Bio Limited - Ordinary Shares | 5.79 USD | -1.53% | -24.90% | +51.57% | -69.04% | 409.87 M USD | ||
| 3019 |  DRUG Bright Minds Biosciences Inc. - common stock | 52.00 USD | 0.00% | +5.39% | -18.72% | -15.72% | 397.06 M USD | ||
| 3020 |  ZURA Zura Bio Limited - Class A Ordinary shares | 4.13 USD | -0.96% | -1.90% | -25.32% | -5.28% | 395.77 M USD | ||
| 3049 |  KYTX Kyverna Therapeutics, Inc. - Common Stock | 6.18 USD | +0.16% | -6.65% | -17.71% | -12.09% | 382.19 M USD | ||
| 3066 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.63 USD | +2.61% | +1.63% | -7.65% | +15.04% | 372.76 M USD | ||
| 3071 |  IRD Opus Genetics, Inc. - Common Stock | 4.46 USD | +1.13% | -2.19% | -24.15% | +19.89% | 371.05 M USD | ||
| 3078 |  GALT Galectin Therapeutics Inc. - Common Stock | 3.64 USD | +0.55% | -4.71% | -9.00% | -23.69% | 367.09 M USD | ||
| 3082 |  ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 12.87 USD | +0.78% | -3.45% | -10.06% | -35.55% | 365.80 M USD | ||
| 3109 |  ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 12.10 USD | -2.18% | -6.71% | -7.56% | +5.13% | 352.42 M USD | ||
| 3114 |  CCCC C4 Therapeutics, Inc. - Common Stock | 2.85 USD | +1.06% | -10.66% | -16.18% | +15.85% | 350.62 M USD | ||
| 3129 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.73 USD | +1.24% | -10.47% | -0.17% | +96.91% | 344.40 M USD | ||
| 3139 |  AGEN Agenus Inc. - Common Stock | 7.54 USD | -0.40% | -9.81% | +11.54% | +77.00% | 339.45 M USD | ||
| 3140 |  TTRX Turn Therapeutics Inc. - Common Stock | 11.39 USD | -5.87% | -14.68% | -14.62% | +38.06% | 339.29 M USD | ||
| 3142 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 3.17 USD | -2.46% | -14.78% | -25.41% | +41.52% | 338.14 M USD | ||
| 3156 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 6.80 USD | -2.86% | -1.31% | -36.45% | +63.46% | 332.45 M USD | ||
| 3158 |  OCGN Ocugen, Inc. - Common Stock | 0.98 USD | -2.00% | -5.77% | -10.91% | -46.15% | 332.33 M USD | ||
| 3162 |  CABA Cabaletta Bio, Inc. - Common Stock | 1.95 USD | -1.02% | +0.52% | -31.58% | -38.29% | 330.61 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |